93 related articles for article (PubMed ID: 3465437)
1. Mechanism of interaction between antineoplastic agents and natural differentiation factors in the induction of human leukemic cell maturation.
Honma Y; Honma C; Bloch A
Cancer Res; 1986 Dec; 46(12 Pt 1):6311-5. PubMed ID: 3465437
[TBL] [Abstract][Full Text] [Related]
2. Macromolecular and cell cycle effects of different classes of agents inducing the maturation of human myeloblastic leukemia (ML-1) cells.
Craig RW; Frankfurt OS; Sakagami H; Takeda K; Bloch A
Cancer Res; 1984 Jun; 44(6):2421-9. PubMed ID: 6586286
[TBL] [Abstract][Full Text] [Related]
3. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
Yamamoto-Yamaguchi Y; Makishima M; Kanatani Y; Kasukabe T; Honma Y
Exp Hematol; 1996 May; 24(6):682-9. PubMed ID: 8635523
[TBL] [Abstract][Full Text] [Related]
4. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
[TBL] [Abstract][Full Text] [Related]
5. Erythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562.
Tonini GP; Radzioch D; Gronberg A; Clayton M; Blasi E; Benetton G; Varesio L
Cancer Res; 1987 Sep; 47(17):4544-7. PubMed ID: 3476195
[TBL] [Abstract][Full Text] [Related]
6. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade.
Liebermann DA; Hoffman-Liebermann B
Oncogene; 1989 May; 4(5):583-92. PubMed ID: 2471131
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of interaction between DNA-specific antitumor agents and serum-contained cytokines in the initiation of ML-1 human myeloblastic leukemia cell differentiation.
Bloch A
Leukemia; 1993 Aug; 7(8):1219-24. PubMed ID: 8350621
[TBL] [Abstract][Full Text] [Related]
8. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
[TBL] [Abstract][Full Text] [Related]
9. Different regulation of N- and c-myc expression during phorbol ester-induced maturation of human SH-SY5Y neuroblastoma cells.
Hammerling U; Bjelfman C; Påhlman S
Oncogene; 1987; 2(1):73-7. PubMed ID: 3325885
[TBL] [Abstract][Full Text] [Related]
10. Modulation of nuclear proto-oncogene expression and cellular growth in myeloid leukemic cells by human interferon alpha.
Marshall AH; Alper D; Hiscott J
J Cell Physiol; 1988 May; 135(2):324-31. PubMed ID: 3163696
[TBL] [Abstract][Full Text] [Related]
11. Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation.
Chen Q; DeFrances MC; Zarnegar R
Cell Growth Differ; 1996 Jun; 7(6):821-32. PubMed ID: 8780895
[TBL] [Abstract][Full Text] [Related]
12. Differentiation induction in the human rhabdomyosarcoma cell line TE-671. A morphological, biochemical and molecular analysis.
Ramp U; Gerharz CD; Engers R; Marx N; Gabbert HE
Anticancer Res; 1995; 15(1):181-8. PubMed ID: 7733631
[TBL] [Abstract][Full Text] [Related]
13. Increased c-myc RNA levels associated with the precommitment state during HL-60 myeloid differentiation.
Yen A; Guernsey DL
Cancer Res; 1986 Aug; 46(8):4156-61. PubMed ID: 3460694
[TBL] [Abstract][Full Text] [Related]
14. Induction of differentiation in human myeloid leukemic cells by proteolytic enzymes.
Fibach E; Treves A; Kidron M; Mayer M
J Cell Physiol; 1985 May; 123(2):228-34. PubMed ID: 3884635
[TBL] [Abstract][Full Text] [Related]
15. Transient induction of c-fos and c-myc in an immediate consequence of growth factor stimulation.
Curran T; Bravo R; Müller R
Cancer Surv; 1985; 4(4):655-81. PubMed ID: 3939686
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
[TBL] [Abstract][Full Text] [Related]
17. Differentiation-induced ML-1 cells as targets for transformation by a chemical carcinogen.
Guan XP; Bloch A
Cancer Res; 1988 Aug; 48(15):4389-94. PubMed ID: 3164646
[TBL] [Abstract][Full Text] [Related]
18. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
19. Guanosine 5'-triphosphate induces differentiation-dependent apoptosis in human leukemia U937 and KG1 cells.
Yazdanparast R; Moosavi MA; Mahdavi M; Lotfi A
Acta Pharmacol Sin; 2006 Sep; 27(9):1175-84. PubMed ID: 16923338
[TBL] [Abstract][Full Text] [Related]
20. Induction of differentiation of cultured mouse monocytic leukemia cells (Mm-A) by inducers different from those of parent myeloblastic leukemia cells (M1).
Kasukabe T; Honma Y; Hozumi M
Jpn J Cancer Res; 1985 Nov; 76(11):1056-63. PubMed ID: 3936826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
